| scholarly article | Q13442814 |
| P2093 | author name string | Wen Hu | |
| Liang Cheng | |||
| Xiaoqing Wang | |||
| Qingjun Li | |||
| Ziyu Liu | |||
| Yaojun Ni | |||
| De Huai | |||
| Hairong Hao | |||
| Surong Wen | |||
| Weinan Yu | |||
| P2860 | cites work | Intradialytic Hypoxemia in Chronic Hemodialysis Patients | Q28078508 |
| Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese | Q28477784 | ||
| Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes | Q33695887 | ||
| Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment | Q33943374 | ||
| Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus | Q34887952 | ||
| Obstructive sleep apnea is associated with increased urinary albumin excretion. | Q35995542 | ||
| Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program | Q36129822 | ||
| Effects of varying degrees of intermittent hypoxia on proinflammatory cytokines and adipokines in rats and 3T3-L1 adipocytes | Q37500257 | ||
| Novel biomarkers in glomerular disease | Q37658483 | ||
| Review article: Managing sleep apnoea in kidney diseases | Q37752504 | ||
| Transoral robotic sleep surgery: the obstructive sleep apnea-hypopnea syndrome | Q38216613 | ||
| The emerging role of fibroblast growth factor 21 in diabetic nephropathy | Q38750211 | ||
| Cobalt chloride decreases fibroblast growth factor-21 expression dependent on oxidative stress but not hypoxia-inducible factor in Caco-2 cells | Q41358608 | ||
| The prevalence and characteristics of obstructive sleep apnea in hospitalized patients with type 2 diabetes in China. | Q41488132 | ||
| Nocturnal intermittent hypoxia as an associated risk factor for microalbuminuria in Japanese patients with type 2 diabetes mellitus | Q43450740 | ||
| Prevalence and associated factors of obstructive sleep apnea in hospitalized patients with type 2 diabetes in Beijing, China 2. | Q44063191 | ||
| Diabetes and sleep disturbances: findings from the Sleep Heart Health Study | Q44319108 | ||
| Prevalence and determinants of albuminuria in a cohort of diabetic patients in Lebanon | Q46244912 | ||
| Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice | Q46640076 | ||
| Obstructive sleep apnoea in diabetes: Does it matter? | Q47721289 | ||
| The effect of sleep apnea syndrome on the development of diabetic nephropathy in patients with type 2 diabetes | Q48227239 | ||
| Resolution of proteinuria in a patient with focal segmental glomerulosclerosis following BiPAP initiation for obesity hypoventilation syndrome | Q48268623 | ||
| Association between serum fibroblast growth factor 21 and diabetic nephropathy. | Q51364488 | ||
| Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR). | Q51543810 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 1357-1368 | |
| P577 | publication date | 2019-06-06 | |
| P1433 | published in | Diabetes Therapy | Q26853803 |
| P1476 | title | Association of OSAHS Hypoxia Indicators with Early Renal Injury and Serum Fibroblast Growth Factor 21 in Obese Type 2 Diabetic Patients | |
| P478 | volume | 10 |
Search more.